Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.
The herbal hair serum effectively promotes hair growth, reduces dandruff, and enhances shine with minimal side effects.
Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.
April 2025 in “International Journal of Homoeopathic Sciences” Homeopathy helped treat alopecia totalis by addressing emotional stress and immune support.
March 2025 in “Journal of the European Academy of Dermatology and Venereology” Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.
March 2025 in “NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES” Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.
March 2025 in “International Journal of Dermatology” Baricitinib may help people with long-term alopecia areata.
March 2025 in “BioNanoScience” The new minoxidil hydrogel improves delivery and is safe for treating hair loss.
Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.
Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.
Bacopa monniera promotes hair growth, enhances memory, and helps with inflammation and stomach issues.
February 2025 in “Canadian Journal of Health Technologies” Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.
BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.
January 2025 in “Journal of Cutaneous Immunology and Allergy” Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.
January 2025 in “Nutrients” Genetic factors and diet significantly increase the risk of male pattern baldness.
January 2025 in “Balkan Medical Journal” Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib significantly regrows hair in severe alopecia areata patients.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.
January 2025 in “Orvosi Hetilap” The SASI bypass surgery leads to significant weight loss and improves health conditions with minimal absorption issues.
January 2025 in “Frontiers in Pediatrics” Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.
January 2025 in “International Journal of Dermatology” Afro-textured hair in indigenous South Africans has lower density and unique features, needing specific evaluation standards.
January 2025 in “Geneesmiddelenbulletin” Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.
January 2025 in “Dermatologic Therapy” Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.
January 2025 in “Journal of Materials Chemistry B” A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.
The patch effectively promotes hair growth for alopecia areata without pain.
January 2025 in “The Egyptian Journal of Hospital Medicine” Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.
January 2025 in “Dermatologic Therapy” Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.
January 2025 in “Зоологический журнал / Russian Journal of Zoology” Baikal seals' skin shows normal adaptations and potential pathologies possibly linked to climate change and a viral pathogen.
January 2025 in “International Journal of Pharmacognosy and Pharmaceutical Research” Bacopa monnieri extract can significantly inhibit cell division.